<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Colorectal Dis</journal-id><journal-id journal-id-type="iso-abbrev">Int J Colorectal Dis</journal-id><journal-title-group><journal-title>International Journal of Colorectal Disease</journal-title></journal-title-group><issn pub-type="ppub">0179-1958</issn><issn pub-type="epub">1432-1262</issn><publisher><publisher-name>Springer Berlin Heidelberg</publisher-name><publisher-loc>Berlin/Heidelberg</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40407900</article-id><article-id pub-id-type="pmc">PMC12102125</article-id>
<article-id pub-id-type="publisher-id">4883</article-id><article-id pub-id-type="doi">10.1007/s00384-025-04883-0</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Impact of surgical case load on recurrence rates in pilonidal sinus disease: a cross-study data synthesis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Doll</surname><given-names>Dietrich</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Maak</surname><given-names>Matthias</given-names></name><address><email>matthias.maak@uk-erlangen.de</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Faurschou</surname><given-names>Ida Kaad</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Hackmann</surname><given-names>Theo</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>von Sochaczewski</surname><given-names>Christina Oetzmann</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Braun-M&#x000fc;nker</surname><given-names>Myriam</given-names></name><xref ref-type="aff" rid="Aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Iesalnieks</surname><given-names>Igors</given-names></name><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author"><name><surname>Haas</surname><given-names>Susanne</given-names></name><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author"><collab>the Pilonidal Network for Expertise, Research and Development (PiloNERDs International)<contrib-group><contrib contrib-type="author"><name><surname>Doll</surname><given-names>Dietrich</given-names></name></contrib><contrib contrib-type="author"><name><surname>Maak</surname><given-names>Matthias</given-names></name></contrib><contrib contrib-type="author"><name><surname>Haas</surname><given-names>Susanne</given-names></name></contrib><contrib contrib-type="author"><name><surname>Farschou</surname><given-names>Ida</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hougaard</surname><given-names>Helene</given-names></name></contrib><contrib contrib-type="author"><name><surname>S&#x000f8;rensen</surname><given-names>Marlene Julia</given-names></name></contrib><contrib contrib-type="author"><name><surname>Thy&#x000f8;</surname><given-names>Anne Vestbjerg</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hackmann</surname><given-names>Theo</given-names></name></contrib><contrib contrib-type="author"><name><surname>Heitmann</surname><given-names>Henrike</given-names></name></contrib><contrib contrib-type="author"><name><surname>Barbosa</surname><given-names>Sofia</given-names></name></contrib><contrib contrib-type="author"><name><surname>Dettmer</surname><given-names>Marius</given-names></name></contrib><contrib contrib-type="author"><name><surname>von Sochaczewski</surname><given-names>Christina Oetzmann</given-names></name></contrib></contrib-group></collab></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/00f2yqf98</institution-id><institution-id institution-id-type="GRID">grid.10423.34</institution-id><institution-id institution-id-type="ISNI">0000 0000 9529 9877</institution-id><institution>Department of Procto-Surgery &#x00026; Pilonidal Sinus, </institution><institution>St. Marienhospital Vechta, Academic Teaching Hospital of the MHH Hannover, </institution></institution-wrap>Vechta, Germany </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0030f2a11</institution-id><institution-id institution-id-type="GRID">grid.411668.c</institution-id><institution-id institution-id-type="ISNI">0000 0000 9935 6525</institution-id><institution>Department of Surgery, </institution><institution>University Hospital Erlangen of the Friedrich-Alexander University Erlangen-Nuremberg, </institution></institution-wrap>Krankenhausstra&#x000df;e 12, 91054 Erlangen, Germany </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01xnwqx93</institution-id><institution-id institution-id-type="GRID">grid.15090.3d</institution-id><institution-id institution-id-type="ISNI">0000 0000 8786 803X</institution-id><institution>Department of Surgery, </institution><institution>University Hospital of Bonn, Venusberg-Campus Bonn, </institution></institution-wrap>Bonn, Germany </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/05n00ke18</institution-id><institution-id institution-id-type="GRID">grid.415677.6</institution-id><institution-id institution-id-type="ISNI">0000 0004 0646 8878</institution-id><institution>Department of Surgery, </institution><institution>Randers Regional Hospital, </institution></institution-wrap>Randers, Denmark </aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/041bz9r75</institution-id><institution-id institution-id-type="GRID">grid.430588.2</institution-id><institution-id institution-id-type="ISNI">0000 0001 0705 4827</institution-id><institution>Department of Food Technology, </institution><institution>Fulda University of Applied Sciences, </institution></institution-wrap>Leipziger Stra&#x000df;e 123, 36037 Fulda, Germany </aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0124s1j61</institution-id><institution-id institution-id-type="GRID">grid.477199.5</institution-id><institution-id institution-id-type="ISNI">0000 0004 0389 9672</institution-id><institution>Department of Surgery, </institution><institution>Evangelisches Krankenhaus Kalk, </institution></institution-wrap>Cologne, Germany </aff></contrib-group><pub-date pub-type="epub"><day>23</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="pmc-release"><day>23</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="ppub"><year>2025</year></pub-date><volume>40</volume><issue>1</issue><elocation-id>126</elocation-id><history><date date-type="accepted"><day>2</day><month>4</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><sec><title>Purpose</title><p id="Par1">A higher surgical caseload has been associated with better outcomes in various diseases. However, this relationship has not yet been studied for Pilonidal Sinus Disease (PSD). This study aimed to examine the impact of annual PSD surgery volumes on recurrence rates (RR).</p></sec><sec><title>Methods</title><p id="Par2">A comparative cross-study data synthesis was conducted, including 1074 studies with 130,599 patients, focusing on PSD recurrence rates. Studies were categorized based on annual case load (ACL) into three groups: fewer than 10 operations per year (group 1), 10&#x02013;30 operations per year (group 2), and 30 or more operations per year (group 3). Kaplan&#x02013;Meier analyses were performed to evaluate recurrence rates, with additional stratification by study design (randomized controlled trial (RCT) or non-RCT) and surgical treatment type.</p></sec><sec><title>Results</title><p id="Par3">In randomized controlled trials (RCTs) of primary open treatment, group 1 (&#x0003c; 10 surgeries/year) had a 5-year recurrence rate of 23.5%, while group 2 (10&#x02013;30 surgeries/year) had a rate of 12.5% (<italic>p</italic>&#x02009;&#x0003c; 0.0001). No data was available for group 3. For primary midline closure (pmc), the 5-year recurrence rates were 14.8% for group 1, 26.3% for group 2, and 12.8% for group 3. Non-RCT studies generally showed decreasing recurrence rates with higher surgical caseloads for most treatment types. However, midline closure surgery showed no significant improvement in recurrence rates with increased caseloads.</p></sec><sec><title>Conclusion</title><p id="Par4">The study demonstrates that higher surgical caseloads significantly reduce PSD recurrence rates, with notable benefits observed for centers treating 30 or more patients annually. Specialization in high-volume centers may lead to improved outcomes for PSD, particularly in flap surgeries. However, midline closure surgery continues to show persistently high recurrence rates, regardless of caseload.</p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1007/s00384-025-04883-0.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Pilonidal sinus</kwd><kwd>Therapy</kwd><kwd>Long term recurrence rate</kwd><kwd>Incidence</kwd><kwd>Observation bias</kwd><kwd>Case load</kwd><kwd>Operations per year</kwd></kwd-group><funding-group><award-group><funding-source><institution>Universit&#x000e4;tsklinikum Erlangen (8546)</institution></funding-source></award-group><open-access><p>Open Access funding enabled and organized by Projekt DEAL.</p></open-access></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer-Verlag GmbH Germany, part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par5">Pilonidal sinus disease (PSD) is a common but often overlooked surgical condition, primarily affecting adolescents [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Patients frequently experience social stigma and uncertainty in seeking care, while PSD itself lacks a dedicated medical specialty. Management is dispersed across general, colorectal, plastic, and dermatologic surgeons, with no clear ownership, leading to inconsistencies in treatment approaches.</p><p id="Par6">Anal and perianal surgical conditions are often low on medical priority lists, leaving pilonidal abscesses or fistulae to be handled by junior surgeons. While teaching opportunities exist, they are not common. Specialized clinics for teenagers with recurrent PSD provide more focused care, [<xref ref-type="bibr" rid="CR3">3</xref>], compared to hospitals where surgeries are distributed among various practitioners.</p><p id="Par7">Paradoxically, despite the significant patient population, the number of cases handled per physician varies greatly. In 2018, Nora Peters analyzed PSD treatment in German hospitals, revealing annual caseloads ranging from 1 to 160 patients per hospital, with a median of 38 operations per year&#x02014;less than one operation per week [<xref ref-type="bibr" rid="CR4">4</xref>].</p><p id="Par8">Senior consultants (25%), junior consultants (24%), and registrars (27%) predominantly managed PSD cases during daytime hours, with department heads involved in 17% of cases. Notably, 24% of surgeries occurred at night, 10% of which were performed by department heads [<xref ref-type="bibr" rid="CR5">5</xref>].</p><p id="Par9">PSD surgeries are thus distributed across hospitals and performed by various departments or as outpatient procedures. While many physicians feel capable of managing PSD, training for advanced procedures remains limited and is often perceived as inadequate [<xref ref-type="bibr" rid="CR6">6</xref>]. Regular training, with less than one operation per week, may be just sufficient [<xref ref-type="bibr" rid="CR7">7</xref>], but the efficacy of such training remains unknown. Training younger doctors might necessitate further redistribution of surgical cases. Surgical approaches range from primary open and midline closures to rotation and advancement flaps (e.g., Limberg, Karydakis) and minimally invasive techniques like pit-picking, marsupialization, and laser ablation. Hospitals using multiple techniques often perform only a few cases per year per method, contributing to recurrence rates between 18 and 30%&#x000a0;per year [<xref ref-type="bibr" rid="CR5">5</xref>].</p><p id="Par10">Although PSD surgery is technically not a rocket scince, its consequences can be significant, ranging from prolonged hospitalization and recovery to impaired sexual function [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>], frequent dressing changes, and the need for repeat surgeries [<xref ref-type="bibr" rid="CR10">10</xref>]. Asymmetric closures and flap procedures consistently show the lowest recurrence rates [<xref ref-type="bibr" rid="CR11">11</xref>&#x02013;<xref ref-type="bibr" rid="CR13">13</xref>], but mastering them requires experience. Some flap techniques, such as Karydakis, may require as few as 24 procedures to achieve proficiency [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR14">14</xref>], raising concerns about whether surgeons receive adequate training across all methods, like rhomboid procedures, such as Limberg [<xref ref-type="bibr" rid="CR15">15</xref>] and Dufourmentel [<xref ref-type="bibr" rid="CR16">16</xref>].</p><p id="Par11">Recognizing the interplay between decision-making and surgical skill, this study aimed to determine whether annual caseloads per study correlate with recurrence rates in PSD as reported in global literature. The null hypothesis (H&#x02080;) posited no correlation between annual caseloads and recurrence rates.</p></sec><sec id="Sec2"><title>Methods</title><p id="Par12">This study was conducted as part of a larger research project [<xref ref-type="bibr" rid="CR17">17</xref>] and registered in the PROSPERO study register under the title, &#x0201c;The efficacy of the commonest surgical procedures in pilonidal sinus patients&#x02013;a meta-analysis comparing the recurrence rates over time using long-term follow-up data&#x0201d; (PROSPERO 2016 CRD42016051588). The data retrieval process followed the Stauffer methodology [<xref ref-type="bibr" rid="CR13">13</xref>], and the results are presented in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>PRISMA flow chart of study harvest and qualification steps [<xref ref-type="bibr" rid="CR21">21</xref>]. GEK&#x02019;92 =&#x02009;George E. Karydakis study 1992</p></caption><graphic xlink:href="384_2025_4883_Fig1_HTML" id="MO1"/></fig></p><sec id="Sec3"><title>Search strategy and study selection criteria</title><p id="Par13">A preliminary investigation that began in 1986 involved searching the German Bundeswehr Medical Archives (WEHRMEDSTATINST Bw Remagen) under the guidance of the archivists [<xref ref-type="bibr" rid="CR18">18</xref>]. Using pinpoint search techniques, it was discovered that some non-PSD diseases had been incorrectly classified as PSD. Conversely, many PSD cases were misclassified under other conditions. By applying broader search terms, such as &#x0201c;pilonid*&#x0201d; and &#x0201c;dermoid*&#x0201d; combined with &#x0201c;cyst,&#x0201d; previously unrecognized PSD cases were identified and added to the dataset. This approach avoided reliance on ICD or OPS codes and significantly expanded the PSD population, though it required sifting through thousands of irrelevant findings. Ultimately, more than 5% of previously mislabeled reports were incorporated into the database. This methodology, akin to using a fine-mesh fishing net, was adopted to ensure thoroughness in building the PSD world literature database for subsequent research.</p><p id="Par14">A systematic search of the global literature was conducted using the NCBI Medical Subject Heading (MeSH) term &#x0201c;pilonid*&#x0201d; and the combination &#x0201c;dermoid&#x0201d; AND &#x0201c;cyst.&#x0201d; This search covered all available databases, including MEDLINE, PubMed, PubMed Central, Scopus, Ovid, EMBASE, and the Cochrane Central Register of Controlled Trials (CENTRAL). Additional searches using these terms were performed on platforms like Google, Google Scholar, and ResearchGate. References cited in national and international guidelines, such as the S3 guidelines from the Association of the Scientific Medical Societies in Germany for PSD treatment, were also examined. Furthermore, bibliographies of all retrieved documents were reviewed.</p><p id="Par15">The collected materials included a wide range of study types, such as randomized and non-randomized trials, prospective and retrospective studies, and observational studies (e.g., cohort studies, case&#x02013;control studies, cross-sectional studies, and case reports). These documents spanned nearly two centuries, covering the period from 1833 to 2023.</p><p id="Par16">Three authors (TH, HH, DD) meticulously reviewed the retrieved documents to ensure they met the inclusion criteria. These criteria required information on definitive treatment, recurrence rates, gender composition, and follow-up duration. Publications in English, French, German, Italian, and Spanish were included, as well as those in other languages if an English abstract provided details on treatment, recurrence, and follow-up time. When translations were needed, authors were contacted via email or ResearchGate, and, alternatively, two different translation software tools were used to translate relevant text passages.</p><p id="Par17">Exclusion criteria included PSD cases occurring outside the sacral region, involvement of neoplastic conditions, and duplicate publications of the same data by the same author. Studies that lacked any part of the minimal dataset&#x02014;comprising definitive treatment, recurrence, and follow-up information&#x02014;were also excluded. While previous meta-analyses and review articles were not included in the study, their reference lists were carefully reviewed to identify additional evidence. Unpublished data presented within these reviews were also considered for inclusion.</p></sec><sec id="Sec4"><title>Data collection, extraction, and quality assessment</title><p id="Par18">All identified studies underwent a comprehensive analysis and were meticulously documented. The extracted data were transcribed into a Microsoft Excel spreadsheet (Version 2016, Microsoft Corp., Redmond, WA, USA) and verified to ensure accuracy. Each distinct therapeutic strategy reported within a study was recorded on a separate line, with columns detailing citation information, the number of patients, therapeutic procedures, reported follow-up times, study characteristics, and recurrence data.</p><p id="Par19">Due to the variability in statistical measures used to report follow-up times across studies, mean and median values were treated as equivalent, given that PSD predominantly affects young adults. When studies provided minimum follow-up times, these values were incorporated as reported.</p><p id="Par20">Individual studies were systematically reviewed for methodological consistency and accuracy of reported results to minimize potential bias during data synthesis. A subgroup analysis of prospective randomized controlled trials (RCTs) was conducted to ensure alignment with the broader dataset. Recurrence rates from each study were linked to their corresponding follow-up times, whether reported as mean, median, the midpoint of a range, or minimum values.</p><p id="Par21">To enable uniform comparisons across studies, individual patients were statistically simulated. Each study participant was represented as a data sample, capturing their recurrence status, follow-up time, and therapeutic procedure. For instance, if a study included 500 patients and reported a 20% recurrence rate for a specific therapeutic procedure, 100 samples were designated as having recurrent disease, while the remaining 400 were considered recurrence-free.</p><p id="Par22">Certain variables, such as gender ratios, were excluded from the analysis since most studies reported these data in aggregate form. When an article discussed multiple therapeutic strategies, data for each treatment strategy were analyzed separately.</p><p id="Par23">As pediatric pilonidal sinus disease exhibits distinct recurrence rate kinetics, only cohorts with a mean age of 18 years or older were included in this analysis [<xref ref-type="bibr" rid="CR19">19</xref>]. Additional studies employing return-on-recurrence (ROR) follow-up were excluded due to their susceptibility to significant observational bias. This exclusion applied to PSD studies with ROR follow-up as well. Details of this selection process are outlined in the PRISMA schedule (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>).</p><p id="Par24">As recommended by an expert group of statisticians, case reports and case series involving fewer than 10 patients were excluded from the analysis. A prior meta-regression analysis, conducted on a cohort of 89,583 patients, examined both established recurrence rate (RR) modifiers (such as choice of treatment, follow-up duration, age, and Methylene Blue use) and potentially influential variables (including year of therapy, country of treatment, and annual caseload). This analysis confirmed the impact and relative importance of the established factors.</p><p id="Par25">Other potential influences, such as family history and recurrence status (primary versus recurrent disease), were inconsistently reported in the global literature and too limited to allow meaningful analysis. Similarly, cardiovascular comorbidities were rare, as PSD primarily affects patients aged 15 to 25 years. Previous co-interventions were also infrequently documented and, as a result, were not investigated.</p><p id="Par26">For a detailed discussion of potential biases in worldwide database analyses, please refer to the following publication [<xref ref-type="bibr" rid="CR17">17</xref>].</p></sec><sec id="Sec5"><title>Grouping of therapeutic procedures and statistical analyses</title><p id="Par27">Therapeutic procedures were analyzed both collectively (&#x0201c;overall across study design&#x0201d;) and in subcategories based on specific surgical treatment methods.</p><p id="Par28">Is it the total number of cases reported by the study per year of study duration?</p><p id="Par29">The annual caseload calculated by dividing the number of cases for each surgical method by the duration of years of the study. These annual caseloads were then grouped into three categories: &#x0003c;&#x02009;10 operations per year, 10&#x02013; &#x0003c;&#x02009;30 operations per year, and &#x02265;&#x02009;30 operations per year. This grouping resulted in three cohorts comprising 24,165, 49,052, and 57,382 patients, respectively.</p><p id="Par30">The decision to define the first group as &#x0003c;&#x02009;10 operations per year was supported by literature indicating this level represents the early stages of a surgeon&#x02019;s learning curve [<xref ref-type="bibr" rid="CR20">20</xref>], as calculated from Australian data [<xref ref-type="bibr" rid="CR7">7</xref>]. This group is also below the success rate threshold of one of the flap procedures [<xref ref-type="bibr" rid="CR7">7</xref>]. The threshold of &#x02265;&#x02009;30 operations per year was based on Wysocki&#x02019;s findings, which demonstrated that proficiency in flap procedures could be achieved after performing 30 cases in a short period. Additionally, the annual caseload was further sub-grouped by surgical method.</p><p id="Par31">To ensure data reliability, it was assumed that no hospital could publish data on successive patients treated with the same method more than once a year. After reviewing 100 cases of authors publishing twice annually, where different treatment groups were consistently reported, this assumption was validated. Double publications were excluded in accordance with previously outlined criteria.</p></sec><sec id="Sec6"><title>Grouping of therapeutic procedures, gender cohorts, and statistical analyses</title><p id="Par32">Therapeutic procedures were analyzed for RCT and nonRCT and further subcategorized into therapeutic categories. Variants of therapeutic procedures were consolidated under their originating procedures, as outlined in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>).
<table-wrap id="Tab1"><label>Table 1</label><caption><p>Log rank <italic>p</italic>-values f&#x000fc;r RCTs only, comparing the influence of annual case load on recurrence rate for different therapies (Figs.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>, <xref rid="Fig7" ref-type="fig">7</xref>, <xref rid="Fig8" ref-type="fig">8</xref>, <xref rid="Fig9" ref-type="fig">9</xref>, and <xref rid="Fig10" ref-type="fig">10</xref>)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Caseload p.a</th><th align="left">Overall</th><th align="left">Primary open</th><th align="left">Midline closure</th><th align="left">Bascom/Karyd</th><th align="left">Limberg/Duf</th></tr></thead><tbody><tr><td align="left">&#x02009;&#x0003c; 10 vs. 10 &#x0003c;&#x02009;30</td><td char="." align="char"><italic>p</italic>&#x02009;= 0.039</td><td align="left"><bold><italic>p</italic></bold><bold>&#x02009;&#x0003c; 0.0001</bold></td><td char="." align="char"><italic>p</italic>&#x02009;= 0.14</td><td align="left"><bold><italic>p</italic></bold><bold>&#x02009;= 0.0051</bold></td><td char="." align="char"><bold><italic>p</italic></bold><bold>&#x02009;= 0.04825</bold></td></tr><tr><td align="left">&#x02009;&#x0003c; 10 vs. &#x02265;&#x02009;30</td><td char="." align="char"><italic>p</italic>&#x02009;= 0.8</td><td align="left"><bold><italic>p</italic></bold><bold>&#x02009;= 0.00078</bold></td><td char="." align="char"><italic>p</italic>&#x02009;= 0.14</td><td align="left"><bold><italic>p</italic></bold><bold>&#x02009;&#x0003c; 0.0001</bold></td><td char="." align="char"><bold><italic>p</italic></bold><bold>&#x02009;= 0.00013</bold></td></tr><tr><td align="left">10 &#x0003c;&#x02009;30 vs. &#x02265;&#x02009;30</td><td char="." align="char"><italic>p</italic>&#x02009;= 0.039</td><td align="left"><italic>p</italic>&#x02009;= 0.05827</td><td char="." align="char"><italic>p</italic>&#x02009;= 0.14</td><td align="left"><bold><italic>p</italic></bold><bold>&#x02009;= 0.0051</bold></td><td char="." align="char"><bold><italic>p</italic></bold><bold>&#x02009;= 0.04825</bold></td></tr></tbody></table><table-wrap-foot><p>significant values are given in bold</p></table-wrap-foot></table-wrap></p><p id="Par33">Statistical analysis and visualization were performed using the R statistical software package (version 4.3.2) within the RStudio framework (version 2023.6.1.524). Statistical significance was defined as <italic>p</italic>&#x02009;&#x0003c; 0.05, and all tests were two-tailed. Kaplan&#x02013;Meier survival analysis was employed to assess recurrence-free outcomes over time, along with pointwise 95% confidence intervals (CI), using the R package <italic>survival</italic> (version 3.5&#x02013;7). These analyses were conducted for both RCT and non-RCT cohorts, with results presented as the percentage of recurrence-free outcomes and corresponding 95% CIs. Graphical representations were created using the <italic>survminer</italic> package (version 0.4.9), and a two-tailed log-rank test was applied.</p><p id="Par34">For two-group comparisons, Student&#x02019;s <italic>t</italic>-test was used. The horizontal axes of the Kaplan&#x02013;Meier plots indicated the number of patients within specific follow-up intervals, measured in months. Where data for specific intervals were unavailable, linear interpolation was applied to estimate recurrence-free outcomes based on the two nearest observed follow-up times. The analysis timeframe was truncated at 10 years postoperatively.</p><p id="Par35">To provide a comprehensive assessment, data from both RCTs and non-RCTs were evaluated. Due to the incremental nature of Kaplan&#x02013;Meier curves, minor discrepancies between plotted and tabulated values may occur.</p></sec></sec><sec id="Sec7"><title>Results</title><p id="Par36">In total, our analysis included 1074 studies involving 130,599 patients, spanning the years from 1833 to 2023. From these studies, we analyzed the caseload distribution, which is shown in the histogram (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><p>Histogram of annual case load per method; all methods together <italic>n</italic>&#x02009;= 130,599 pts (mean 16 ops p.a., median 9 ops p.a.)</p></caption><graphic xlink:href="384_2025_4883_Fig2_HTML" id="MO2"/></fig></p><p id="Par37">The observed spectrum of caseload per methodology ranges from 1 to 882 patients published annually. The mean caseload per annum stands at 16 patients, with a median of 9 patients. Figure&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>a&#x02013;d illustrates the histogram delineating caseload distribution for the predominant surgical modalities in treating Pilonidal Sinus Disease (PSD).<fig id="Fig3"><label>Fig. 3</label><caption><p><bold>a</bold>&#x02013;<bold>d</bold> Histogram of annual case load for each method of the most used surgical methods. Please note that the <italic>Y</italic>-axes use different scaling</p></caption><graphic xlink:href="384_2025_4883_Fig3a_HTML" id="d33e706"/><graphic xlink:href="384_2025_4883_Fig3b_HTML" id="d33e707"/></fig></p><p id="Par38">As can be seen from the density plots for primary open wound treatment (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>a, above left), midline closure (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>b, above right), Limberg/Dufourmentel (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>c, below left), and Karydakis/Bascom (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>d, below right) and case load means/medians per year and method range between 16/9 (all), 15/7 (primary open), 17/9 (primary midline), 16/10 (Limberg/Dufourmentel), and 20/13 (Karydakis/Bascom) operations per year and study. Primary midline seems to be the most often used method in this cohort analyzed but applied and published in smaller cohorts (despite no longer being recommended) [<xref ref-type="bibr" rid="CR22">22</xref>&#x02013;<xref ref-type="bibr" rid="CR24">24</xref>]. All curves in Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3</xref>a&#x02013;d peak between 5 and 14 operations representing the most common annual case load (ACL) per method worldwide.</p><p id="Par39">When analyzing the trend of ACL reported over the last 30 years, an upward trend is apparent (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>). However, it is unclear whether this trend reflects an actual increase in the number of PSD cases being diagnosed and operated on each year, a result of better detection and treatment, or simply a greater volume of published PSD cases. Specialization of authors, attracting larger numbers of operations, may also be a contributing factor, which is a welcome development.<fig id="Fig4"><label>Fig. 4</label><caption><p>Annual case load histogram per decades; all methods. *The 2030 decade contains the years 2020 following and is incomplete at this time</p></caption><graphic xlink:href="384_2025_4883_Fig4_HTML" id="MO5"/></fig></p><p id="Par40">There is an overall upward trend of annual case load published for all methods combined until the 2020 decade (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4</xref>). It is important to note that the 2030 decade is not yet complete, so this column may be subject to future corrections as more data becomes available.</p><p id="Par41">Figure&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>a&#x02013;d shows the annual case load of these four methods. The annual case load (ACL) of flap methods Karydakis/Bascom (lower left) and Limberg/Dufourmentel (lower right) shows a substantial increase over the last four decades. Surprisingly, the primary open method (upper left) seems to be experiencing a revival, as larger ACLs per hospital are observed in the 2020 decade, which are more than twice as high compared to the previous three decades. Most surprisingly, primary midline therapy is still in use, with its application appearing to increase in the recent decades of 2000&#x02013;2020, after a period of lower yearly case loads from 1960 to 1990. The highest ACL in the 2020 decade is observed in the primary open wound treatment group, while the incomplete 2030 data shows a trend toward Karydakis/Bascom flaps.<fig id="Fig5"><label>Fig. 5</label><caption><p><bold>a</bold>&#x02013;<bold>d</bold> Annual case load per decade, separate for the four most applied surgical methods. *The 2030 decade contains the years 2020 following and is incomplete at this time</p></caption><graphic xlink:href="384_2025_4883_Fig5_HTML" id="MO6"/></fig></p><p id="Par42">As outlined in the methods section, annual case load (ACL) was grouped into &#x0003c;&#x02009;10 operations, 10&#x02013;30 operations, and &#x02265;&#x02009;30 operations per year to create equally sized groups, using cut-offs supported by the literature (<italic>n</italic>&#x02009;= 24,165 patients, <italic>n</italic>&#x02009;= 49,052 patients, and <italic>n</italic>&#x02009;= 57,382 patients, respectively) when analyzing all methods of both RCT and non-RCTs together. Since recurrence rates (RR) may differ between RCTs and non-RCTs [<xref ref-type="bibr" rid="CR17">17</xref>], as noted in the literature, these are analyzed separately as follows.</p></sec><sec id="Sec8"><title>RCT studies</title><p id="Par43">In RCTs only analysis for all treatments (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>), the 5-year recurrence rates (RR) are 13.6% (95% CI 11.5&#x02013;15.5) for ACL &#x0003c;&#x02009;10 (group 1, yellow), 16.1% (95% CI 14.1&#x02013;18.0) for ACL 10&#x02013;30 (group 2, blue), and 21.8% (95% CI 18.5&#x02013;25.0) for ACL &#x02265;&#x02009;30 (group 3, green). The 10-year RR is only available for group 1 and is 25.1% (95% CI 21.5&#x02013;28.5).<fig id="Fig6"><label>Fig. 6</label><caption><p>Recurrence free outcome for all methods combined and associated recurrence rate for different annual case load (ACL), RCTs only</p></caption><graphic xlink:href="384_2025_4883_Fig6_HTML" id="MO7"/></fig></p><p id="Par44">As shown in Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>, the procedure-specific analysis for the primary open treatment group reveals a 5-year recurrence rate of 23.5% (95% CI 16.5&#x02013;29.8) for group 1 and 12.5% (95% CI 7.6&#x02013;17.7) for group 2. No data was available at 5 years of follow-up for group 3, and there was no data for any group at 10 years of follow-up.<fig id="Fig7"><label>Fig. 7</label><caption><p>Recurrence free outcome for primary open method and associated recurrence rate for different ACLs; RCTs only</p></caption><graphic xlink:href="384_2025_4883_Fig7_HTML" id="MO8"/></fig></p><p id="Par45">In the RCT analysis for primary midline closure (Fig.&#x000a0;<xref rid="Fig8" ref-type="fig">8</xref>), the 5-year recurrence rates for groups 1&#x02013;3 are 14.8% (95% CI 11.3&#x02013;18.1), 26.3% (95% CI 22.0&#x02013;30.4), and 12.8% (95% CI 10.6&#x02013;15.0), respectively. The 10-year recurrence rate of 29.9% (95% CI 23.7&#x02013;35.7) is only available for group 1.<fig id="Fig8"><label>Fig. 8</label><caption><p>Recurrence free outcome for primary midline closure and associated recurrence rate for different ACLs; RCTs only</p></caption><graphic xlink:href="384_2025_4883_Fig8_HTML" id="MO9"/></fig></p><p id="Par46">Analysis of Bascom Karydakis treatment in RCT studies only (Fig.&#x000a0;<xref rid="Fig9" ref-type="fig">9</xref>) reveals 5-year recurrence rates of 1.8% (95% CI 0.0&#x02013;3.5%) for group 1, 9.1% (95% CI 4.9&#x02013;13.1%) for group 2, and 30.7% (95% CI 20.2&#x02013;39.9%) for group 3. The 10-year recurrence rate for group 1 is 2.6% (95% CI 0.2&#x02013;5.0%), while no data are available for groups 2 and 3 at that time. Given the small study size for group 1, with limited data beyond 72 months, and the higher recurrence-free outcome in this group compared to groups 2 and 3, these results should be interpreted with caution.<fig id="Fig9"><label>Fig. 9</label><caption><p>Recurrence free outcome for Bascom/Karydakis advancement flap and associated recurrence rate for different ACLs; RCTs only</p></caption><graphic xlink:href="384_2025_4883_Fig9_HTML" id="MO10"/></fig></p><p id="Par47">In RCT analysis of Limberg/Dufourmentel (Fig.&#x000a0;<xref rid="Fig10" ref-type="fig">10</xref>), only short term results (less than 5 years) are available. As shown in Fig.&#x000a0;<xref rid="Fig10" ref-type="fig">10</xref>, the 3-year recurrence rates (RR) are 11.4% (95% CI 6.5&#x02013;16.0%) for group 1, 7.5% (95% CI 4.9&#x02013;10.1%) for group 2, and 5.0% (95% CI 2.6&#x02013;7.4%) for group 3 at 36 months. All three curves differ significantly, with group 3 showing the lowest recurrence rate, group 2 displaying an intermediate recurrence rate, and the group with the lowest annual case load (group 1) showing the highest recurrence rate among the three Limberg/Dufourmentel groups at that time. The results of log-rank testing for the RCT studies and their respective groups are displayed in Table&#x000a0;<xref rid="Tab1" ref-type="table">1</xref>.<fig id="Fig10"><label>Fig. 10</label><caption><p>Recurrence free outcome for Limberg/Dufourmentel rhomboid rotation flap and associated recurrence rate for different ACLs; RCTs only</p></caption><graphic xlink:href="384_2025_4883_Fig10_HTML" id="MO11"/></fig></p></sec><sec id="Sec9"><title>NonRCT studies</title><p id="Par48">Using Kaplan&#x02013;Meier analysis on the larger non-RCT cohort with all therapy groups combined, the recurrence-free outcome was plotted against time since surgery (on the <italic>x</italic>-axis, in months) for the three annual case load (ACL) groups, as shown in Fig.&#x000a0;<xref rid="Fig11" ref-type="fig">11</xref>. The dark green group (ACL &#x02265;&#x02009;30) demonstrates the largest recurrence-free outcome, indicating the lowest recurrence rate over time since surgery.<fig id="Fig11"><label>Fig. 11</label><caption><p>Annual case load per method and consecutive recurrence rate; all methods together in non-RCT analysis</p></caption><graphic xlink:href="384_2025_4883_Fig11_HTML" id="MO12"/></fig></p><p id="Par49">The Kaplan&#x02013;Meier analysis of the larger non-RCT cohort reveals distinct differences in recurrence rates across the three ACL groups, as shown in Fig.&#x000a0;<xref rid="Fig11" ref-type="fig">11</xref>. The lowest line on the graph corresponds to group 1 (ACL &#x0003c;&#x02009;10), which drops significantly below the other two groups, indicating that the recurrence rate is highest in the lowest ACL group. The 5-year and 10-year recurrence rates for ACL &#x0003c;&#x02009;10 were 14.6% (95% CI 13.9&#x02013;15.3) and 28.8% (95% CI 27.6&#x02013;30.0), respectively. In contrast, the recurrence rates for the ACL 10 &#x0003c;&#x02009;30 group were 11.4% (95% CI 11.0&#x02013;11.9) at 5 years and 19.8% (95% CI 19.0&#x02013;20.7) at 10 years. For the ACL &#x02265;&#x02009;30 group, the 5-year recurrence rate was 9.7% (95% CI 9.3&#x02013;10.1), and the 10-year rate was 21.6% (95% CI 20.7&#x02013;22.6). All three curves differed significantly from each other (<italic>p</italic>&#x02009;&#x0003c; 0.0001; log rank test, Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>.
<table-wrap id="Tab2"><label>Table 2</label><caption><p>Log rank test <italic>p</italic>-values for nonRCT Kaplan&#x02013;Meier analysis of case load vs recurrence curves from Figs.&#x000a0;<xref rid="Fig11" ref-type="fig">11</xref>, <xref rid="Fig12" ref-type="fig">12</xref>, <xref rid="Fig13" ref-type="fig">13</xref>, <xref rid="Fig14" ref-type="fig">14</xref>, and <xref rid="Fig15" ref-type="fig">15</xref></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Caseload p.a</th><th align="left">Overall</th><th align="left">Primary open</th><th align="left">Midline closure</th><th align="left">Bascom/Karyd</th><th align="left">Limberg/Duf</th></tr></thead><tbody><tr><td align="left">&#x02009;&#x0003c; 10 vs. 10 &#x0003c;&#x02009;30</td><td align="left"><bold><italic>p</italic></bold><bold>&#x02009;&#x0003c; 0.0001</bold></td><td align="left"><bold><italic>p</italic></bold><bold>&#x02009;&#x0003c; 0.0001</bold></td><td char="." align="char"><italic>p</italic>&#x02009;= 0.13</td><td char="." align="char"><italic>p</italic>&#x02009;= 0.9</td><td align="left"><bold><italic>p</italic></bold><bold>&#x02009;= 0.032</bold></td></tr><tr><td align="left">&#x02009;&#x0003c; 10 vs. &#x02265;&#x02009;30</td><td align="left"><bold><italic>p</italic></bold><bold>&#x02009;&#x0003c; 0.0001</bold></td><td align="left"><bold><italic>p</italic></bold><bold>&#x02009;&#x0003c; 0.0001</bold></td><td char="." align="char"><italic>p</italic>&#x02009;= 0.85</td><td char="." align="char"><italic>p</italic>&#x02009;= 0.9</td><td align="left"><italic>p</italic>&#x02009;= 0.525</td></tr><tr><td align="left">10 &#x0003c;&#x02009;30 vs. &#x02265;&#x02009;30</td><td align="left"><bold><italic>p</italic></bold><bold>&#x02009;&#x0003c; 0.0001</bold></td><td align="left"><bold><italic>p</italic></bold><bold>&#x02009;&#x0003c; 0.0001</bold></td><td char="." align="char"><italic>p</italic>&#x02009;= 0.85</td><td char="." align="char"><italic>p</italic>&#x02009;= 0.9</td><td align="left"><bold><italic>p</italic></bold><bold>&#x02009;&#x0003c; 0.0001</bold></td></tr></tbody></table><table-wrap-foot><p>significant values are given in bold</p></table-wrap-foot></table-wrap></p><p id="Par50">Further analysis of different therapy subgroups within the non-RCT cohort shows that for the primary open group (Fig.&#x000a0;<xref rid="Fig7" ref-type="fig">7</xref>): the ACL &#x02265;&#x02009;30 group exhibited the best recurrence-free outcome (i.e., the lowest recurrence rate). For this group, the 5-year recurrence rate was as low as 3.1% (95% CI 2.5&#x02013;3.8%). The ACL 10 &#x0003c;&#x02009;30 group had a recurrence rate that was intermediate between the largest and smallest ACL groups, with a 5-year recurrence rate of 8.3% (95% CI 7.3&#x02013;9.3) and a 10-year recurrence rate of 13.3% (95% CI 11.9&#x02013;14.7). In contrast, the ACL &#x0003c;&#x02009;10 group had the highest recurrence rate, with a 5-year rate of 12.0% (95% CI 10.4&#x02013;13.5) and a 10-year rate of 24.0% (95% CI 21.2&#x02013;26.7). Again, all three curves differed significantly (<italic>p</italic>&#x02009;&#x0003c; 0.0001; log rank test).</p><p id="Par51">These findings suggest that while higher caseloads (&#x02265; 30 operations per year) seem statistically comparable in terms of long-term recurrence rates, the smallest group (ACL &#x0003c;&#x02009;10) clearly stands apart, with higher recurrence rates both in the short- and long-term follow-up periods (Fig.&#x000a0;<xref rid="Fig12" ref-type="fig">12</xref>).<fig id="Fig12"><label>Fig. 12</label><caption><p>Annual case load for primary open method and consecutive recurrence rate; nonRCTs</p></caption><graphic xlink:href="384_2025_4883_Fig12_HTML" id="MO13"/></fig></p><p id="Par52">The Kaplan&#x02013;Meier analysis of recurrence rates for primary midline closure (pmc) (Fig.&#x000a0;<xref rid="Fig13" ref-type="fig">13</xref>) reveals consistently high recurrence rates across all three ACL groups. The 5-year recurrence rates are 15.9% (95% CI 14.7&#x02013;17.2) for group 1 (ACL &#x0003c;&#x02009;10), 14.6% (95% CI 13.2&#x02013;15.9) for group 2 (ACL 10 &#x0003c;&#x02009;30), and 11.9% (95% CI 11.0&#x02013;12.8) for group 3 (ACL &#x02265;&#x02009;30). At 10 years, the recurrence rates remain similarly high, with group 1 showing a rate of 25.6% (95% CI 23.7&#x02013;27.5) and group 2 showing 25.2% (95% CI 23.1&#x02013;27.3). However, no data are available for group 3 at the 10-year follow-up. Notably, at 96 months, all three curves converge, indicating that, despite initial differences, the recurrence rates for the three ACL groups become similar over time.<fig id="Fig13"><label>Fig. 13</label><caption><p>Annual case load for primary midline method and consecutive recurrence rate</p></caption><graphic xlink:href="384_2025_4883_Fig13_HTML" id="MO14"/></fig></p><p id="Par53">In a similar pattern to the primary midline closure, the Kaplan&#x02013;Meier curves for Bascom/Karydakis (Fig.&#x000a0;<xref rid="Fig14" ref-type="fig">14</xref>) and Limberg/Dufourmentel (Fig.&#x000a0;<xref rid="Fig15" ref-type="fig">15</xref>) therapies also remain closely aligned but show lower recurrence rates. For Bascom/Karydakis therapy, the 5-year recurrence rates are 8.0% (95% CI 6.2&#x02013;9.6) for group 1 (ACL &#x0003c;&#x02009;10), 7.7% (95% CI 6.6&#x02013;8.8) for group 2 (ACL 10 &#x0003c;&#x02009;30), and no data available for group 3 (ACL &#x02265;&#x02009;30). The recurrence rates between these groups are statistically similar, with a <italic>p</italic>-value of 0.9 for all comparisons. In Limberg/Dufourmentel therapy, the 5-year recurrence rates are 7.2% (95% CI 5.7&#x02013;8.6) for group 1 (ACL &#x0003c;&#x02009;10), 4.2% (95% CI 3.5&#x02013;4.9) for group 2 (ACL 10 &#x0003c;&#x02009;30), and 11.5% (95% CI 9.4&#x02013;13.5) for group 3 (ACL &#x02265;&#x02009;30). The recurrence rates for these groups indicate some variation, with the group 2 (ACL 10 &#x0003c;&#x02009;30) showing the lowest rate.<fig id="Fig14"><label>Fig. 14</label><caption><p>Annual case load for Bascom Karydakis method and consecutive recurrence rate</p></caption><graphic xlink:href="384_2025_4883_Fig14_HTML" id="MO15"/></fig><fig id="Fig15"><label>Fig. 15</label><caption><p>Annual case load for Limberg and Dufourmentel method and consecutive recurrence rate</p></caption><graphic xlink:href="384_2025_4883_Fig15_HTML" id="MO16"/></fig></p><p id="Par54">The <italic>p</italic>-values for the nonRCT comparison of the influence of annual case load (ACL) on recurrence rates across all therapies (&#x0201c;overall&#x0201d;), primary open therapy (po), Bascom/Karydakis, and Limberg/Dufourmentel therapies can be found in Table&#x000a0;<xref rid="Tab2" ref-type="table">2</xref>.</p></sec><sec id="Sec10"><title>Discussion</title><p id="Par55">This is the most comprehensive cross-study data synthesis comparing the influence of annual case load (ACL) on the recurrence rate of pilonidal sinus disease (PSD) across multiple surgical techniques. Our findings underscore the importance of surgical volume in influencing recurrence rates of pilonidal sinus disease (PSD), particularly in low-volume hospitals. The analysis reveals that hospitals with an annual caseload (ACL) of fewer than 10 cases show significantly higher recurrence rates, and outcomes improve as the ACL increases, particularly in hospitals performing &#x0003e;&#x02009;30 cases per year. However, while the differences observed were statistically significant, we acknowledge that the clinical significance of these findings, especially for high-volume centers, may not be as pronounced as initially expected. Notably, the results from randomized controlled trials (RCTs) show relatively smaller differences in recurrence rates between groups, suggesting that factors beyond surgical volume&#x02014;such as technique refinement, surgeon experience, and patient-specific characteristics&#x02014;also play a crucial role in outcomes. In particular, flap techniques like the Bascom/Karydakis and Limberg/Dufourmentel procedures showed reliably low recurrence rates, even when performed in centers with moderate volumes. This points to the fact that, once mastered, these techniques can maintain consistent outcomes, regardless of case volume, and highlights the role of surgical expertise in achieving favorable results.</p><p id="Par56">However, primary midline closure&#x02014;an outdated technique [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR25">25</xref>&#x02013;<xref ref-type="bibr" rid="CR28">28</xref>]&#x02014;consistently yields poor results, regardless of experience. This underscores the importance of both surgical expertise and technique selection in PSD management. Interestingly, while the 5-year and 10-year recurrence rates for the Bascom/Karydakis and Limberg/Dufourmentel techniques differ in RCT analysis, they remain consistent in the nonRCT analysis, with no apparent effect of annual case load (ACL) in our cohort of 29,178 patients. This pattern may be explained by a variety of factors, particularly the nature of flap or asymmetric techniques, which, despite being perceived as more complex due to potential complications [<xref ref-type="bibr" rid="CR6">6</xref>], have seen an increase in use per hospital over time (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>c&#x02013;d). This suggests that once surgeons master flap procedures, outcomes remain consistent, independent of volume. Flap techniques, though initially complex, are increasingly adopted and refined by dedicated specialists, reflecting broader acceptance and improved proficiency over time. This aligns with the rising number of records found in the databases when searching for these specific keywords, suggesting that the technique is becoming more mainstream.</p><p id="Par57">Selective publication bias appears unlikely, as recurrence rates have remained stable over five decades despite rising PSD incidence [<xref ref-type="bibr" rid="CR29">29</xref>]. If publication bias were a major influence, we would expect to see more exaggerated positive results. Instead, the stable recurrence rates, coupled with the increasing use of flap techniques, support the notion that these procedures may indeed be improving over time, independent of case load. Interestingly, prior surgical interventions did not clearly influence recurrence rates in this study. Methylene blue (MB), commonly used for intraoperative tract delineation, leading to larger excisions, longer wound healing [<xref ref-type="bibr" rid="CR30">30</xref>], and contributing to lower recurrence rates [<xref ref-type="bibr" rid="CR31">31</xref>], was evenly distributed across ACL groups, suggesting it is not a confounding factor.</p><p id="Par58">Wysocki&#x02019;s findings [<xref ref-type="bibr" rid="CR7">7</xref>] support the notion that supervised training in flap surgery significantly improves outcomes. In contrast, midline closure continues to yield poor results in adults. Despite numerous studies highlighting its ineffectiveness, midline closure is still performed in about 10% of German hospitals [<xref ref-type="bibr" rid="CR5">5</xref>], with similar practices observed in Austria, Switzerland, and the UK [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. In Denmark, the use of midline closure has been decreasing, partly due to national training initiatives promoting alternative methods such as pit picking and cleft lift surgery [<xref ref-type="bibr" rid="CR34">34</xref>].</p></sec><sec id="Sec11"><title>Limitations</title><p id="Par59">This study is limited by its retrospective design and heterogeneity among included studies. This approach incorporated both randomized controlled trials (RCTs) and non-RCT studies, intentionally excluding return-on-recurrence studies due to their potential observational bias [<xref ref-type="bibr" rid="CR35">35</xref>].</p><p id="Par60">Mean recurrence rates were analyzed at different time points, and Kaplan&#x02013;Meier data were not consistently available. As a result, heterogeneity exists within the dataset, prompting us to adapt our statistical methods accordingly.</p><p id="Par61">It is important to acknowledge that surgeons likely treat a larger number of patients than is reflected in their published figures, suggesting that their practical expertise may exceed the scope of the reported cohorts. Additionally, individual surgeon volumes could not be determined, as PSD surgeries are performed by surgeons of varying experience levels within hospitals, therefore it not possible to determine how the cases are distributed in a unit performing 30 cases per year.</p><p id="Par62">Patient-related factors allegedly related to recurrence&#x02014;such as smoking, diabetes, BMI, hair removal, and lifestyle&#x02014;were not examined, though their random distribution likely minimizes bias. Furthermore, poor outcomes in primary open surgery may stem from inadequate technique, such as incomplete tract resection or improper wound management, or later embedding of hair into the long-time open wound causing future recurrences, adding to the effects of a low annual case load.</p><p id="Par63">Our results suggest there is potential for improvement in the primary open technique, particularly in hospitals with lower PSD case loads, as indicated by our data. Several factors may contribute to suboptimal outcomes in primary open treatment, such as failure to apply methylene blue, improper resection of all tracts, or unnecessarily&#x000a0;excising the wound too close to the anus. Acute abscess-forming disease, for instance, benefits from two-stage surgery [<xref ref-type="bibr" rid="CR36">36</xref>] and shows a lower recurrence rate when performed during the daytime [<xref ref-type="bibr" rid="CR37">37</xref>]. A common error in primary open treatment is exposing the sacral fascia, a practice that has been discouraged since the early twentieth century [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR39">39</xref>]. This exposure allows skin and wound bacteria to access the fascia, a bradytrophic&#x000a0;tissue with limited blood supply, which leads to infection and delayed healing. Prolonged inflammation in this tissue reduces its ability to combat infection and initiate the necessary processes for tissue repair and wound healing. Furthermore, partial closure or leaving the wound open can facilitate the entry of hair, potentially leading to recurrent disease.</p><p id="Par64">Kaplan et al. [<xref ref-type="bibr" rid="CR40">40</xref>] found that prolonged healing times increased recurrence risk, particularly in younger patients. Similarly, Demiryas and Donmez [<xref ref-type="bibr" rid="CR41">41</xref>] linked wound infections and dehiscence to higher recurrence rates, raising the question of whether less experienced surgeons create larger wounds, increasing infection risks. Alternatively, other technical factors may contribute to the observed higher infection and recurrence rates in such cases. [<xref ref-type="bibr" rid="CR42">42</xref>].</p></sec><sec id="Sec12"><title>Implications and conclusion</title><p id="Par65">Our findings highlight the need for specialization and possibly centralization of PSD treatment, similar to Denmark&#x02019;s restructuring of colorectal cancer care [<xref ref-type="bibr" rid="CR43">43</xref>&#x02013;<xref ref-type="bibr" rid="CR45">45</xref>]. Establishing national and international standards for surgical volume and quality monitoring could improve outcomes [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR37">37</xref>&#x02013;<xref ref-type="bibr" rid="CR42">42</xref>].</p><p id="Par66">This cross-study data synthesis of 130,599 patients confirms that annual case load significantly influences recurrence rates, particularly in low-volume hospitals. While high ACL improves outcomes, flap surgery remains effective even at moderate volumes when performed by trained specialists. The continued use of midline closure should be abandoned in favor of evidence-based techniques. Ultimately, surgical expertise&#x02014;guided by experience and proper training&#x02014;is the key determinant of PSD treatment success.</p></sec><sec id="Sec13" sec-type="supplementary-material"><title>Supplementary Information</title><p>Below is the link to the electronic supplementary material.<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="384_2025_4883_MOESM1_ESM.docx"><caption><p>Supplementary file1 (DOCX 17 KB)</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="384_2025_4883_MOESM2_ESM.pdf"><caption><p>Supplementary file2 (PDF 248 KB)</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="384_2025_4883_MOESM3_ESM.docx"><caption><p>Supplementary file3 (DOCX 31 KB)</p></caption></media></supplementary-material></p></sec></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The great and continuous help of Henrike Heitmann and Marcel Bonni is kindly acknowledged.</p><p>The Members of the Pilonidal Network for Expertise, Research and Development (PiloNERDs Group) are the following:</p><p>Dietrich&#x000a0;Doll, Vechta, GER</p><p>Marcel Bonni, Bad Zwischenahn, GER</p><p>Imke Brengelmann, Vechta, GER</p><p>Marius Dettmer, Koblenz, GER</p><p>Maja Diekmann, Vechta, GER</p><p>Ida Kaad Faurschou, Randers, DK</p><p>Susanne Haas, Randers, DK</p><p>Theo Hackmann, Vechta, GER</p><p>Henrike Heitmann, Vechta, GER</p><p>Helene Hougaard, Randers, DK</p><p>Igors Iesalnieks, K&#x000f6;ln, GER</p><p>Johannes Jongen, Kiel, GER</p><p>Matthias Maak, H&#x000f6;chstadt a. d. Aisch, GER</p><p>Christina Oetzmann von Sochaczewski, Bonn, GER</p><p>Firas Safadi, Annaberg-Buchholz, GER</p><p>Jannik Seifert, Vechta, GER</p><p>Marlene Julia S&#x000f8;rensen, Randers, DK</p><p>Anne Vestbjerg Thy&#x000f8;, Randers, DK</p></ack><notes notes-type="author-contribution"><title>Author contribution</title><p>Main manuscript draft by Dietrich Doll, Ida Kaad Faurschou, Matthias Maak, and Theo Hackmann. Reviewing of the main manuscript and final approvel by Dietrich Doll, Matthias Maak, Ida Kaad Faurschou, Theo Hackmann, Christina Oetzmann von Sochaczewski, Myriam Braun-M&#x000fc;nker, Igors Iesalnieks, and Susanne Haas. Study concept by Dietrich Doll, Igors Iesalnieks, and Susanne Haas. Data acquisition by Dietrich Doll, Ida Kaad Faurschou, and Theo Hackmann. Figures preparation by Dietrich Doll, Matthias Maak, Christina Oetzmann von Sochaczewski, and Myriam Braun-M&#x000fc;nker. Data analysis and interpretation by Dietrich Doll, Matthias Maak, Ida Kaad Faurschou, Theo Hackmann, Christina Oetzmann von Sochaczewski, Myriam Braun-M&#x000fc;nker, Igors Iesalnieks, Susanne Haas.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Open Access funding enabled and organized by Projekt DEAL.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>No datasets were generated or analysed during the current study.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval</title><p id="Par67">This review does not contain any personal data nor interventions that could potentially cause harm to human participants. Nevertheless, Ethic standards according to the Declaration of Helsinki were applied in full [<xref ref-type="bibr" rid="CR46">46</xref>].</p></notes><notes id="FPar2" notes-type="COI-statement"><title>Competing interests</title><p id="Par68">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Oetzmann von Sochaczewski</surname><given-names>C</given-names></name><name><surname>Godeke</surname><given-names>J</given-names></name></person-group><article-title>Pilonidal sinus disease on the rise: a one-third incidence increase in inpatients in 13 years with substantial regional variation in Germany</article-title><source>Int J Colorectal Dis</source><year>2021</year><volume>36</volume><issue>10</issue><fpage>2135</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1007/s00384-021-03944-4</pub-id><pub-id pub-id-type="pmid">33993341</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Oetzmann von Sochaczewski C, Godeke J (2021) Pilonidal sinus disease on the rise: a one-third incidence increase in inpatients in 13 years with substantial regional variation in Germany. Int J Colorectal Dis 36(10):2135&#x02013;45<pub-id pub-id-type="pmid">33993341</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Ardelt</surname><given-names>M</given-names></name><name><surname>Dennler</surname><given-names>U</given-names></name><name><surname>Fahrner</surname><given-names>R</given-names></name><name><surname>Hallof</surname><given-names>G</given-names></name><name><surname>Tautenhahn</surname><given-names>HM</given-names></name><name><surname>Dondorf</surname><given-names>F</given-names></name><etal/></person-group><article-title>Die Pubert&#x000e4;t ist ein wichtiger Faktor bei der Pilonidalsinuserkrankung. Geschlechtsspezifische Untersuchung der Fallzahlentwicklung in Deutschland 2007 bis 2015</article-title><source>Chirurg</source><year>2017</year><volume>88</volume><issue>11</issue><fpage>961</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1007/s00104-017-0463-7</pub-id><pub-id pub-id-type="pmid">28667368</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Ardelt M, Dennler U, Fahrner R, Hallof G, Tautenhahn HM, Dondorf F et al (2017) Die Pubert&#x000e4;t ist ein wichtiger Faktor bei der Pilonidalsinuserkrankung. Geschlechtsspezifische Untersuchung der Fallzahlentwicklung in Deutschland 2007 bis 2015. Chirurg 88(11):961&#x02013;7<pub-id pub-id-type="pmid">28667368</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Delshad</surname><given-names>HR</given-names></name><name><surname>Henry</surname><given-names>O</given-names></name><name><surname>Mooney</surname><given-names>DP</given-names></name></person-group><article-title>Improving resource utilization and outcomes using a minimally invasive pilonidal protocol</article-title><source>J Pediatr Surg</source><year>2020</year><volume>55</volume><issue>1</issue><fpage>182</fpage><lpage>186</lpage><pub-id pub-id-type="doi">10.1016/j.jpedsurg.2019.09.074</pub-id><pub-id pub-id-type="pmid">31676078</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Delshad HR, Henry O, Mooney DP (2020) Improving resource utilization and outcomes using a minimally invasive pilonidal protocol. J Pediatr Surg 55(1):182&#x02013;186<pub-id pub-id-type="pmid">31676078</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>Schneider</surname><given-names>R</given-names></name><name><surname>Dettmer</surname><given-names>M</given-names></name><name><surname>Peters</surname><given-names>N</given-names></name><name><surname>Lamdark</surname><given-names>T</given-names></name><name><surname>Luedi</surname><given-names>MM</given-names></name><name><surname>Adamina</surname><given-names>M</given-names></name><etal/></person-group><article-title>The current status of surgical pilonidal sinus disease therapy in Germany</article-title><source>Eur Surg</source><year>2021</year><volume>54</volume><fpage>117</fpage><lpage>125</lpage><pub-id pub-id-type="doi">10.1007/s10353-021-00715-x</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Schneider R, Dettmer M, Peters N, Lamdark T, Luedi MM, Adamina M et al (2021) The current status of surgical pilonidal sinus disease therapy in Germany. Eur Surg 54:117&#x02013;125</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="other">Peters N (2019) Das operative Therapiespektrum des prim&#x000e4;ren und rekurrierenden Pilonidalsinus &#x02013; eine deutschlandweite Klinikbefragung. Dissertation,&#x000a0;Saarland University of Homburg</mixed-citation></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Loganathan</surname><given-names>A</given-names></name><name><surname>Arsalani Zadeh</surname><given-names>R</given-names></name><name><surname>Hartley</surname><given-names>J</given-names></name></person-group><article-title>Pilonidal disease: time to reevaluate a common pain in the rear!</article-title><source>Dis Colon Rectum</source><year>2012</year><volume>55</volume><issue>4</issue><fpage>491</fpage><lpage>493</lpage><pub-id pub-id-type="doi">10.1097/DCR.0b013e31823fe06c</pub-id><pub-id pub-id-type="pmid">22426275</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Loganathan A, Arsalani Zadeh R, Hartley J (2012) Pilonidal disease: time to reevaluate a common pain in the rear! Dis Colon Rectum 55(4):491&#x02013;493<pub-id pub-id-type="pmid">22426275</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Wysocki</surname><given-names>AP</given-names></name></person-group><article-title>Defining the learning curve for the modified Karydakis flap</article-title><source>Tech Coloproctol</source><year>2015</year><volume>19</volume><issue>12</issue><fpage>753</fpage><lpage>755</lpage><pub-id pub-id-type="doi">10.1007/s10151-015-1393-3</pub-id><pub-id pub-id-type="pmid">26568052</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Wysocki AP (2015) Defining the learning curve for the modified Karydakis flap. Tech Coloproctol 19(12):753&#x02013;755<pub-id pub-id-type="pmid">26568052</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Furnee</surname><given-names>EJ</given-names></name><name><surname>Davids</surname><given-names>PH</given-names></name><name><surname>Pronk</surname><given-names>A</given-names></name><name><surname>Smakman</surname><given-names>N</given-names></name></person-group><article-title>Pit excision with phenolisation of the sinus tract versus radical excision in sacrococcygeal pilonidal sinus disease: study protocol for a single centre randomized controlled trial</article-title><source>Trials</source><year>2015</year><volume>16</volume><fpage>92</fpage><pub-id pub-id-type="doi">10.1186/s13063-015-0613-5</pub-id><pub-id pub-id-type="pmid">25872666</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Furnee EJ, Davids PH, Pronk A, Smakman N (2015) Pit excision with phenolisation of the sinus tract versus radical excision in sacrococcygeal pilonidal sinus disease: study protocol for a single centre randomized controlled trial. Trials 16:92<pub-id pub-id-type="pmid">25872666</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Pronk</surname><given-names>A</given-names></name><name><surname>Kastelijns</surname><given-names>L</given-names></name><name><surname>Smakman</surname><given-names>N</given-names></name><name><surname>Furnee</surname><given-names>E</given-names></name></person-group><article-title>Sexual function in patients suffering from sacrococcygeal pilonidal sinus disease</article-title><source>Cureus</source><year>2020</year><volume>12</volume><issue>3</issue><fpage>e7159</fpage><pub-id pub-id-type="pmid">32257702</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Pronk A, Kastelijns L, Smakman N, Furnee E (2020) Sexual function in patients suffering from sacrococcygeal pilonidal sinus disease. Cureus 12(3):e7159<pub-id pub-id-type="pmid">32257702</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>Doll</surname><given-names>D</given-names></name><name><surname>Luedi</surname><given-names>MM</given-names></name><name><surname>Evers</surname><given-names>T</given-names></name><name><surname>Kauf</surname><given-names>P</given-names></name><name><surname>Matevossian</surname><given-names>E</given-names></name></person-group><article-title>Recurrence-free survival, but not surgical therapy per se, determines 583 patients&#x02019; long-term satisfaction following primary pilonidal sinus surgery</article-title><source>Int J Colorectal Dis</source><year>2015</year><volume>30</volume><issue>5</issue><fpage>605</fpage><lpage>611</lpage><pub-id pub-id-type="doi">10.1007/s00384-015-2130-0</pub-id><pub-id pub-id-type="pmid">25687246</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">Doll D, Luedi MM, Evers T, Kauf P, Matevossian E (2015) Recurrence-free survival, but not surgical therapy per se, determines 583 patients&#x02019; long-term satisfaction following primary pilonidal sinus surgery. Int J Colorectal Dis 30(5):605&#x02013;611<pub-id pub-id-type="pmid">25687246</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Petersen</surname><given-names>S</given-names></name><name><surname>Koch</surname><given-names>R</given-names></name><name><surname>Stelzner</surname><given-names>S</given-names></name><name><surname>Wendlandt</surname><given-names>TP</given-names></name><name><surname>Ludwig</surname><given-names>K</given-names></name></person-group><article-title>Primary closure techniques in chronic pilonidal sinus: a survey of the results of different surgical approaches</article-title><source>Dis Colon Rectum</source><year>2002</year><volume>45</volume><issue>11</issue><fpage>1458</fpage><lpage>1467</lpage><pub-id pub-id-type="doi">10.1007/s10350-004-6451-2</pub-id><pub-id pub-id-type="pmid">12432292</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Petersen S, Koch R, Stelzner S, Wendlandt TP, Ludwig K (2002) Primary closure techniques in chronic pilonidal sinus: a survey of the results of different surgical approaches. Dis Colon Rectum 45(11):1458&#x02013;1467<pub-id pub-id-type="pmid">12432292</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Baur</surname><given-names>T</given-names></name><name><surname>Stauffer</surname><given-names>VK</given-names></name><name><surname>Vogt</surname><given-names>AP</given-names></name><name><surname>Kauf</surname><given-names>P</given-names></name><name><surname>Schmid</surname><given-names>M</given-names></name><name><surname>Luedi</surname><given-names>MM</given-names></name><etal/></person-group><article-title>Recurrence rates after uncommon surgical procedures for pilonidal sinus disease - A merged data analysis</article-title><source>Coloproctology</source><year>2019</year><volume>41</volume><issue>2</issue><fpage>96</fpage><lpage>100</lpage><pub-id pub-id-type="doi">10.1007/s00053-018-0313-1</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Baur T, Stauffer VK, Vogt AP, Kauf P, Schmid M, Luedi MM et al (2019) Recurrence rates after uncommon surgical procedures for pilonidal sinus disease - A merged data analysis. Coloproctology 41(2):96&#x02013;100</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Stauffer</surname><given-names>VK</given-names></name><name><surname>Luedi</surname><given-names>M</given-names></name><name><surname>Kauf</surname><given-names>P</given-names></name><name><surname>Schmid</surname><given-names>M</given-names></name><name><surname>Diekmann</surname><given-names>M</given-names></name><name><surname>Wieferich</surname><given-names>K</given-names></name><etal/></person-group><article-title>Common surgical procedures in pilonidal sinus disease: a meta-analysis, merged data analysis, and comprehensive study on recurrence</article-title><source>Sci Rep</source><year>2018</year><volume>8</volume><issue>1</issue><fpage>1</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1038/s41598-018-20143-4</pub-id><pub-id pub-id-type="pmid">29311619</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Stauffer VK, Luedi M, Kauf P, Schmid M, Diekmann M, Wieferich K et al (2018) Common surgical procedures in pilonidal sinus disease: a meta-analysis, merged data analysis, and comprehensive study on recurrence. Sci Rep 8(1):1&#x02013;28<pub-id pub-id-type="pmid">29311619</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Karydakis</surname><given-names>GE</given-names></name></person-group><article-title>New approach to the problem of pilonidal sinus</article-title><source>The Lancet</source><year>1973</year><volume>2</volume><issue>7843</issue><fpage>1414</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(73)92803-1</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Karydakis GE (1973) New approach to the problem of pilonidal sinus. The Lancet 2(7843):1414&#x02013;5</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="other">Limberg AA (1946) Mathematical principles of local plastic procedures on the surface of the human body. In: Literature GPHfM (ed.) Leningrad (St. Petersburg): Medgiz</mixed-citation></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Dufourmentel</surname><given-names>C</given-names></name></person-group><article-title>La fermeture des pertes de substance cutanee limitees. Le lambeau de rotation en L pour losange, dit "LLL"</article-title><source>Ann Chir Plast</source><year>1962</year><volume>7</volume><fpage>61</fpage><lpage>6</lpage></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Dufourmentel C (1962) La fermeture des pertes de substance cutanee limitees. Le lambeau de rotation en L pour losange, dit &#x0201c;LLL.&#x0201d; Ann Chir Plast 7:61&#x02013;6</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="other">Maak M, Sochaczewski COv, Safadi F, Hackmann T, Faurschou IK, Stauffer V, Luedi MM, Iesalnieks I, Doll D, PiloNERDs_International (2025) The PiloNERDs global database: worldwide recurrence rates and surgical efficacy in pilonidal sinus disease - a comprehensive systematic review. (in submission)</mixed-citation></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Sievert</surname><given-names>H</given-names></name><name><surname>Evers</surname><given-names>T</given-names></name><name><surname>Matevossian</surname><given-names>E</given-names></name><name><surname>Hoenemann</surname><given-names>C</given-names></name><name><surname>Hoffmann</surname><given-names>S</given-names></name><name><surname>Doll</surname><given-names>D</given-names></name></person-group><article-title>The influence of lifestyle (smoking and body mass index) on wound healing and long-term recurrence rate in 534 primary pilonidal sinus patients</article-title><source>Int J Colorectal Dis</source><year>2013</year><volume>28</volume><issue>11</issue><fpage>1555</fpage><lpage>1562</lpage><pub-id pub-id-type="doi">10.1007/s00384-013-1731-8</pub-id><pub-id pub-id-type="pmid">23780586</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Sievert H, Evers T, Matevossian E, Hoenemann C, Hoffmann S, Doll D (2013) The influence of lifestyle (smoking and body mass index) on wound healing and long-term recurrence rate in 534 primary pilonidal sinus patients. Int J Colorectal Dis 28(11):1555&#x02013;1562<pub-id pub-id-type="pmid">23780586</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="other">Doll D, Haas S, Faurschou IK, Hackmann T, Heitmann H, Braun-M&#x000fc;nker M, Sochaczewski COv (2025) Pediatric pilonidal sinus disease: recurrence rates of different age groups compared to adults.&#x000a0;Surgery Open Science&#x000a0;23:50&#x02013;6</mixed-citation></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Hopper</surname><given-names>AN</given-names></name><name><surname>Jamison</surname><given-names>MH</given-names></name><name><surname>Lewis</surname><given-names>WG</given-names></name></person-group><article-title>Learning curves in surgical practice</article-title><source>Postgrad Med J</source><year>2007</year><volume>83</volume><issue>986</issue><fpage>777</fpage><lpage>779</lpage><pub-id pub-id-type="doi">10.1136/pgmj.2007.057190</pub-id><pub-id pub-id-type="pmid">18057179</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Hopper AN, Jamison MH, Lewis WG (2007) Learning curves in surgical practice. Postgrad Med J 83(986):777&#x02013;779<pub-id pub-id-type="pmid">18057179</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Liberati</surname><given-names>A</given-names></name><name><surname>Altman</surname><given-names>DG</given-names></name><name><surname>Tetzlaff</surname><given-names>J</given-names></name><name><surname>Mulrow</surname><given-names>C</given-names></name><name><surname>Gotzsche</surname><given-names>PC</given-names></name><name><surname>Ioannidis</surname><given-names>JP</given-names></name><etal/></person-group><article-title>The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration</article-title><source>PLoS Med</source><year>2009</year><volume>6</volume><issue>7</issue><fpage>1</fpage><lpage>28</lpage><pub-id pub-id-type="doi">10.1371/journal.pmed.1000100</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 6(7):1&#x02013;28</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Iesalnieks</surname><given-names>I</given-names></name><name><surname>Ommer</surname><given-names>A</given-names></name><name><surname>Petersen</surname><given-names>S</given-names></name><name><surname>Doll</surname><given-names>D</given-names></name><name><surname>Herold</surname><given-names>A</given-names></name></person-group><article-title>German national guideline on the management of pilonidal disease</article-title><source>Langenbecks Arch Surg</source><year>2016</year><volume>401</volume><issue>5</issue><fpage>599</fpage><lpage>609</lpage><pub-id pub-id-type="doi">10.1007/s00423-016-1463-7</pub-id><pub-id pub-id-type="pmid">27311698</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Iesalnieks I, Ommer A, Petersen S, Doll D, Herold A (2016) German national guideline on the management of pilonidal disease. Langenbecks Arch Surg 401(5):599&#x02013;609<pub-id pub-id-type="pmid">27311698</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Ommer</surname><given-names>A</given-names></name><name><surname>Iesalnieks</surname><given-names>I</given-names></name><name><surname>Doll</surname><given-names>D</given-names></name></person-group><article-title>S3-Leitlinie: Sinus pilonidalis. 2. revidierte Fassung 2020</article-title><source>Coloproctology</source><year>2021</year><volume>43</volume><issue>1</issue><fpage>25</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1007/s00053-020-00488-z</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Ommer A, Iesalnieks I, Doll D (2021) S3-Leitlinie: Sinus pilonidalis. 2. revidierte Fassung 2020. Coloproctology 43(1):25&#x02013;73</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson</surname><given-names>EK</given-names></name><name><surname>Vogel</surname><given-names>JD</given-names></name><name><surname>Cowan</surname><given-names>ML</given-names></name><name><surname>Feingold</surname><given-names>DL</given-names></name><name><surname>Steele</surname><given-names>SR</given-names></name></person-group><article-title>The american society of colon and rectal surgeons&#x02019; clinical practice guidelines for the management of pilonidal disease</article-title><source>Dis Colon Rectum</source><year>2019</year><volume>62</volume><issue>2</issue><fpage>146</fpage><lpage>157</lpage><pub-id pub-id-type="doi">10.1097/DCR.0000000000001237</pub-id><pub-id pub-id-type="pmid">30640830</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Johnson EK, Vogel JD, Cowan ML, Feingold DL, Steele SR (2019) The american society of colon and rectal surgeons&#x02019; clinical practice guidelines for the management of pilonidal disease. Dis Colon Rectum 62(2):146&#x02013;157<pub-id pub-id-type="pmid">30640830</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Iesalnieks</surname><given-names>I</given-names></name><name><surname>Ommer</surname><given-names>A</given-names></name><name><surname>Herold</surname><given-names>A</given-names></name><name><surname>Doll</surname><given-names>D</given-names></name></person-group><article-title>German National Guideline on the management of pilonidal disease: update</article-title><source>Langenbeck&#x02019;s Archives of Surgery</source><year>2020</year><volume>2021</volume><fpage>1</fpage><lpage>22</lpage></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Iesalnieks I, Ommer A, Herold A, Doll D (2020) German National Guideline on the management of pilonidal disease: update. Langenbeck&#x02019;s Archives of Surgery 2021:1&#x02013;22</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Ommer</surname><given-names>A</given-names></name><name><surname>Iesalnieks</surname><given-names>I</given-names></name><name><surname>Doll</surname><given-names>D</given-names></name></person-group><article-title>Pilonidal sinus/sinus pilonidalis</article-title><source>Coloproctology</source><year>2021</year><volume>43</volume><issue>1</issue><fpage>59</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1007/s00053-021-00514-8</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Ommer A, Iesalnieks I, Doll D (2021) Pilonidal sinus/sinus pilonidalis. Coloproctology 43(1):59&#x02013;69</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Allen-Mersh</surname><given-names>TG</given-names></name></person-group><article-title>Pilonidal sinus: finding the right track for treatment</article-title><source>J Br Surg</source><year>1990</year><volume>77</volume><issue>2</issue><fpage>123</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1002/bjs.1800770203</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Allen-Mersh TG (1990) Pilonidal sinus: finding the right track for treatment. J Br Surg 77(2):123&#x02013;32</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Khamis</surname><given-names>A</given-names></name><name><surname>McCallum</surname><given-names>I</given-names></name><name><surname>King</surname><given-names>PM</given-names></name><name><surname>Bruce</surname><given-names>J</given-names></name></person-group><article-title>Healing by primary versus secondary intention after surgical treatment for pilonidal sinus</article-title><source>Cochrane Database Syst Rev </source><year>2010</year><volume>1</volume><fpage>CD006213</fpage></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Al-Khamis A, McCallum I, King PM, Bruce J (2010) Healing by primary versus secondary intention after surgical treatment for pilonidal sinus. Cochrane Database Syst Rev 1:CD006213</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Doll</surname><given-names>D</given-names></name><name><surname>Braun-M&#x000fc;nker</surname><given-names>M</given-names></name><name><surname>Oetzmann von Sochaczewski</surname><given-names>C</given-names></name><name><surname>Iesalnieks</surname><given-names>I</given-names></name></person-group><article-title>Worldwide trends in pilonidal sinus disease recurrence rate</article-title><source>Coloproctology</source><year>2023</year><volume>45</volume><issue>5</issue><fpage>326</fpage><lpage>31</lpage><pub-id pub-id-type="doi">10.1007/s00053-023-00727-z</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="journal">Doll D, Braun-M&#x000fc;nker M, Oetzmann von Sochaczewski C, Iesalnieks I (2023) Worldwide trends in pilonidal sinus disease recurrence rate. Coloproctology 45(5):326&#x02013;31</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><mixed-citation publication-type="other">Kooistra HP (1942)&#x000a0;Pilonidal sinuses - review of literature and report of 350 cases.&#x000a0;Am J Surg 55(1):3&#x02013;17</mixed-citation></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Doll</surname><given-names>D</given-names></name><name><surname>Novotny</surname><given-names>A</given-names></name><name><surname>Rothe</surname><given-names>R</given-names></name><name><surname>Kristiansen</surname><given-names>JE</given-names></name><name><surname>Wietelmann</surname><given-names>K</given-names></name><name><surname>Boulesteix</surname><given-names>AL</given-names></name><etal/></person-group><article-title>Methylene Blue halves the long-term recurrence rate in acute pilonidal sinus disease</article-title><source>Int J Colorectal Dis</source><year>2008</year><volume>23</volume><issue>2</issue><fpage>181</fpage><lpage>187</lpage><pub-id pub-id-type="doi">10.1007/s00384-007-0393-9</pub-id><pub-id pub-id-type="pmid">17960395</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Doll D, Novotny A, Rothe R, Kristiansen JE, Wietelmann K, Boulesteix AL et al (2008) Methylene Blue halves the long-term recurrence rate in acute pilonidal sinus disease. Int J Colorectal Dis 23(2):181&#x02013;187<pub-id pub-id-type="pmid">17960395</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><mixed-citation publication-type="other">Lamdark T, Vuille-Dit-Bille RN, Bielicki IN, Guglielmetti LC, Choudhury RA, Peters N, et al. Treatment strategies for pilonidal sinus disease in Switzerland and Austria. treatment spectrum DACH suisse; Lit Do nora diss. Medicina 56:1&#x02013;8</mixed-citation></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>MJ</given-names></name><name><surname>Strong</surname><given-names>EB</given-names></name><name><surname>Lund</surname><given-names>J</given-names></name><name><surname>Hind</surname><given-names>D</given-names></name><name><surname>Brown</surname><given-names>SR</given-names></name><collab>Group PM</collab></person-group><article-title>A survey of treatment preferences of UK surgeons in the treatment of pilonidal sinus disease</article-title><source>Colorectal Dis</source><year>2023</year><volume>25</volume><fpage>2010</fpage><lpage>2016</lpage><pub-id pub-id-type="doi">10.1111/codi.16696</pub-id><pub-id pub-id-type="pmid">37583061</pub-id>
</element-citation><mixed-citation id="mc-CR33" publication-type="journal">Lee MJ, Strong EB, Lund J, Hind D, Brown SR, Group PM (2023) A survey of treatment preferences of UK surgeons in the treatment of pilonidal sinus disease. Colorectal Dis 25:2010&#x02013;2016<pub-id pub-id-type="pmid">37583061</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>Fabricius</surname><given-names>R</given-names></name><name><surname>Petersen</surname><given-names>LW</given-names></name><name><surname>Bertelsen</surname><given-names>CA</given-names></name></person-group><article-title>Treatment of pilonidal sinuses in Denmark is not optimal</article-title><source>Dan Med Bull</source><year>2010</year><volume>57</volume><issue>12</issue><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">20569653</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">Fabricius R, Petersen LW, Bertelsen CA (2010) Treatment of pilonidal sinuses in Denmark is not optimal. Dan Med Bull 57(12):1&#x02013;5<pub-id pub-id-type="pmid">20569653</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><mixed-citation publication-type="other">Doll D, Haas S, Faurschou IK, Hackmann T, Braun-M&#x000fc;nker M, Sochaczewski COv, PiloNERDs_International (2025) Unveiling return-on-recurrence observation bias in pilonidal sinus disease studies: a comparative analysis of study designs and follow-up protocols.&#x000a0;Pol J Surg (accepted)</mixed-citation></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Doll</surname><given-names>D</given-names></name><name><surname>Matevossian</surname><given-names>E</given-names></name><name><surname>Hoenemann</surname><given-names>C</given-names></name><name><surname>Hoffmann</surname><given-names>S</given-names></name></person-group><article-title>Incision and drainage preceding definite surgery achieves lower 20-year long-term recurrence rate in 583 primary pilonidal sinus surgery patients</article-title><source>J Dtsch Dermatol Ges</source><year>2013</year><volume>11</volume><issue>1</issue><fpage>60</fpage><lpage>64</lpage><pub-id pub-id-type="pmid">23078365</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Doll D, Matevossian E, Hoenemann C, Hoffmann S (2013) Incision and drainage preceding definite surgery achieves lower 20-year long-term recurrence rate in 583 primary pilonidal sinus surgery patients. J Dtsch Dermatol Ges 11(1):60&#x02013;64<pub-id pub-id-type="pmid">23078365</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Doll</surname><given-names>D</given-names></name><name><surname>Evers</surname><given-names>T</given-names></name><name><surname>Krapohl</surname><given-names>B</given-names></name><name><surname>Matevossian</surname><given-names>E</given-names></name></person-group><article-title>Is there a difference in outcome (long-term recurrence rate) between emergency and elective pilonidal sinus surgery?</article-title><source>Minerva Chir</source><year>2013</year><volume>68</volume><issue>2</issue><fpage>199</fpage><lpage>205</lpage><pub-id pub-id-type="pmid">23612234</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Doll D, Evers T, Krapohl B, Matevossian E (2013) Is there a difference in outcome (long-term recurrence rate) between emergency and elective pilonidal sinus surgery? Minerva Chir 68(2):199&#x02013;205<pub-id pub-id-type="pmid">23612234</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Martina</surname><given-names>A</given-names></name></person-group><article-title>&#x000dc;ber kongenitale sacrococcygeale Fisteln</article-title><source>Deutsche Zeitschrift f&#x000fc;r Chirurgie</source><year>1905</year><volume>80</volume><fpage>354</fpage><lpage>365</lpage><pub-id pub-id-type="doi">10.1007/BF02791391</pub-id></element-citation><mixed-citation id="mc-CR38" publication-type="journal">Martina A (1905) &#x000dc;ber kongenitale sacrococcygeale Fisteln. Deutsche Zeitschrift f&#x000fc;r Chirurgie 80:354&#x02013;365</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Swenson</surname><given-names>SA</given-names></name><name><surname>Harkins</surname><given-names>HN</given-names></name><name><surname>Groesbeck</surname><given-names>HP</given-names></name></person-group><article-title>Pilonidal sinus-clinical experiences with the Rogers operation in thirty-five consecutive cases</article-title><source>Am J Surg</source><year>1944</year><volume>66</volume><issue>1</issue><fpage>49</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1016/S0002-9610(44)90226-6</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Swenson SA, Harkins HN, Groesbeck HP (1944) Pilonidal sinus-clinical experiences with the Rogers operation in thirty-five consecutive cases. Am J Surg 66(1):49&#x02013;57</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Kaplan</surname><given-names>M</given-names></name><name><surname>Ozcan</surname><given-names>O</given-names></name><name><surname>Bilgic</surname><given-names>E</given-names></name><name><surname>Kaplan</surname><given-names>ET</given-names></name><name><surname>Kaplan</surname><given-names>T</given-names></name><name><surname>Kaplan</surname><given-names>FC</given-names></name></person-group><article-title>Distal scar-to-midline distance in pilonidal Limberg flap surgery is a recurrence promoting factor: a multicenter, case-control study</article-title><source>Am J Surg</source><year>2017</year><volume>214</volume><issue>5</issue><fpage>811</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1016/j.amjsurg.2017.02.008</pub-id><pub-id pub-id-type="pmid">28359560</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Kaplan M, Ozcan O, Bilgic E, Kaplan ET, Kaplan T, Kaplan FC (2017) Distal scar-to-midline distance in pilonidal Limberg flap surgery is a recurrence promoting factor: a multicenter, case-control study. Am J Surg 214(5):811&#x02013;9<pub-id pub-id-type="pmid">28359560</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Demiryas</surname><given-names>S</given-names></name><name><surname>Donmez</surname><given-names>T</given-names></name></person-group><article-title>Could early postoperative complications be considered as risk factor for recurrence after pilonidal sinus surgery?</article-title><source>Chirurgia</source><year>2019</year><volume>114</volume><issue>4</issue><fpage>475</fpage><lpage>486</lpage><pub-id pub-id-type="doi">10.21614/chirurgia.114.4.475</pub-id><pub-id pub-id-type="pmid">31511134</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">Demiryas S, Donmez T (2019) Could early postoperative complications be considered as risk factor for recurrence after pilonidal sinus surgery? Chirurgia 114(4):475&#x02013;486<pub-id pub-id-type="pmid">31511134</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><mixed-citation publication-type="other">Iesalnieks I, Deimel S, Denecke S, Z&#x000fc;lke C, Schlitt HJ (2012) Lernkurve: Ursache der mangelnden Akzeptanz der plastischen Rekonstruktionsverfahren in der Behandlung des Sinus pilonidalis? 129 Kongress der Deutschen Gesellschaft f&#x000fc;r Chirurgie; 23.04.2012; Berlin: German Medical Science GMS Publishing House, D&#x000fc;sseldorf</mixed-citation></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Iversen</surname><given-names>LH</given-names></name><name><surname>Harling</surname><given-names>H</given-names></name><name><surname>Laurberg</surname><given-names>S</given-names></name><name><surname>Wille-Jorgensen</surname><given-names>P</given-names></name><collab>Danish colorectal cancer Group</collab></person-group><article-title>Influence of caseload and surgical speciality on outcome following surgery for colorectal cancer: a review of evidence. Part 2: long-term outcome</article-title><source>Colorectal Dis</source><year>2007</year><volume>9</volume><issue>1</issue><fpage>38</fpage><lpage>46</lpage><pub-id pub-id-type="doi">10.1111/j.1463-1318.2006.01095.x</pub-id><pub-id pub-id-type="pmid">17181844</pub-id>
</element-citation><mixed-citation id="mc-CR43" publication-type="journal">Iversen LH, Harling H, Laurberg S, Wille-Jorgensen P, Danish colorectal cancer Group (2007) Influence of caseload and surgical speciality on outcome following surgery for colorectal cancer: a review of evidence. Part 2: long-term outcome. Colorectal Dis 9(1):38&#x02013;46<pub-id pub-id-type="pmid">17181844</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name><surname>Iversen</surname><given-names>LH</given-names></name><name><surname>Norgaard</surname><given-names>M</given-names></name><name><surname>Jepsen</surname><given-names>P</given-names></name><name><surname>Jacobsen</surname><given-names>J</given-names></name><name><surname>Christensen</surname><given-names>MM</given-names></name><name><surname>Gandrup</surname><given-names>P</given-names></name><etal/></person-group><article-title>Trends in colorectal cancer survival in northern Denmark: 1985&#x02013;2004</article-title><source>Colorectal Dis</source><year>2007</year><volume>9</volume><issue>3</issue><fpage>210</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1111/j.1463-1318.2006.01130.x</pub-id><pub-id pub-id-type="pmid">17298618</pub-id>
</element-citation><mixed-citation id="mc-CR44" publication-type="journal">Iversen LH, Norgaard M, Jepsen P, Jacobsen J, Christensen MM, Gandrup P et al (2007) Trends in colorectal cancer survival in northern Denmark: 1985&#x02013;2004. Colorectal Dis 9(3):210&#x02013;7<pub-id pub-id-type="pmid">17298618</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Jensen</surname><given-names>KK</given-names></name><name><surname>Andersen</surname><given-names>P</given-names></name><name><surname>Erichsen</surname><given-names>R</given-names></name><name><surname>Scheike</surname><given-names>T</given-names></name><name><surname>Iversen</surname><given-names>LH</given-names></name><name><surname>Krarup</surname><given-names>PM</given-names></name></person-group><article-title>Decreased risk of surgery for small bowel obstruction after laparoscopic colon cancer surgery compared with open surgery: a nationwide cohort study</article-title><source>Surg Endosc</source><year>2016</year><volume>30</volume><issue>12</issue><fpage>5572</fpage><lpage>5582</lpage><pub-id pub-id-type="doi">10.1007/s00464-016-4930-x</pub-id><pub-id pub-id-type="pmid">27129566</pub-id>
</element-citation><mixed-citation id="mc-CR45" publication-type="journal">Jensen KK, Andersen P, Erichsen R, Scheike T, Iversen LH, Krarup PM (2016) Decreased risk of surgery for small bowel obstruction after laparoscopic colon cancer surgery compared with open surgery: a nationwide cohort study. Surg Endosc 30(12):5572&#x02013;5582<pub-id pub-id-type="pmid">27129566</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><mixed-citation publication-type="other">World Medical Association&#x000a0;(1964) Declaration of Helsinki - ethical principles for medical research involving human subjects.&#x000a0;<ext-link ext-link-type="uri" xlink:href="http://www.wma.net/en/30publications/10policies/b3/">http://www.wma.net/en/30publications/10policies/b3/</ext-link>. Accessed 31 Mar 2025</mixed-citation></ref></ref-list></back></article>